Literature DB >> 10716369

Predominance of subtype A and G HIV type 1 in Nigeria, with geographical differences in their distribution.

M Peeters1, E Esu-Williams, L Vergne, C Montavon, C Mulanga-Kabeya, T Harry, A Ibironke, D Lesage, D Patrel, E Delaporte.   

Abstract

The purpose of this study was to generate data on the relative prevalences of the HIV-1 subtypes circulating in Nigeria. A total of 252 HIV-1-positive samples collected during an epidemiologic survey conducted in April 1996 were genetically characterized by HMA (heteroduplex mobility assay) and/or sequencing. Samples were collected in Lagos, Calabar, Kano, and Maiduguri. Overall, the predominant env subtypes were A (61.3%) and G (37.5%). Subtype A is more prevalent in the south (p < 0.001), about 70% in Lagos and Calabar, whereas a quarter of the samples was classified as subtype G in these states. In contrast, subtype G is predominant in the north ( < 0.001), representing 58% of the samples in Kano. In the northeastern region, Maiduguri, almost similar proportions of subtype A and G were seen, 49 and 47.4%, respectively. A total of 37 samples was also sequenced in the p24 region from the gag gene; 13 (35%) had discordant subtype designations between env and gag. The majority of the gag (12 of 17) and env (14 of 22) subtype A sequences clustered with the A/G-IBNG strain. Within subtype G, three different subclusters were seen among the envelope sequences. These different subclusters are observed among samples obtained from asymptomatic individuals and AIDS patients from the four Nigerian states studied. In conclusion, we observed a limited number of HIV-1 subtypes circulating in Nigeria, with subtypes A and G being the major env subtypes responsible for the HIV-1 epidemic. Nevertheless, the high rate of recombinant viruses (A/G) and the different A/G recombinant structures indicate a complex pattern of HIV-1 viruses circulating in this country.

Entities:  

Mesh:

Year:  2000        PMID: 10716369     DOI: 10.1089/088922200309197

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  27 in total

1.  Impact of HIV type 1 subtype on drug resistance mutations in Nigerian patients failing first-line therapy.

Authors:  B Chaplin; G Eisen; J Idoko; D Onwujekwe; E Idigbe; I Adewole; W Gashau; S Meloni; A D Sarr; J L Sankalé; E Ekong; R L Murphy; P Kanki
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-21       Impact factor: 2.205

2.  Phylogenetic mapping of recombination hotspots in human immunodeficiency virus via spatially smoothed change-point processes.

Authors:  Vladimir N Minin; Karin S Dorman; Fang Fang; Marc A Suchard
Journal:  Genetics       Date:  2006-12-28       Impact factor: 4.562

3.  Identification and characterization of CRF02_AG, CRF06_cpx, and CRF09_cpx recombinant subtypes in Mali, West Africa.

Authors:  Hiromi Imamichi; Ousmane Koita; Djeneba Dabitao; Sounkalo Dao; Mahamadou Ibrah; Dramane Sogoba; Robin L Dewar; Steve C Berg; Min-Kang Jiang; Mark Parta; Janice A Washington; Michael A Polis; H Clifford Lane; Anatole Tounkara
Journal:  AIDS Res Hum Retroviruses       Date:  2009-01       Impact factor: 2.205

4.  Viral Genetic Diversity and Polymorphisms in a Cohort of HIV-1-Infected Patients Eligible for Initiation of Antiretroviral Therapy in Abuja, Nigeria.

Authors:  Karidia Diallo; Du-Ping Zheng; Erin K Rottinghaus; Orji Bassey; Chunfu Yang
Journal:  AIDS Res Hum Retroviruses       Date:  2015-02-05       Impact factor: 2.205

5.  Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa.

Authors:  N Vidal; M Peeters; C Mulanga-Kabeya; N Nzilambi; D Robertson; W Ilunga; H Sema; K Tshimanga; B Bongo; E Delaporte
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

6.  Molecular epidemiology of human immunodeficiency virus type 1 sub-subtype A3 in Senegal from 1988 to 2001.

Authors:  Seema Thakore Meloni; Jean-Louis Sankalé; Donald J Hamel; Geoffrey Eisen; Aissatou Guéye-Ndiaye; Souleymane Mboup; Phyllis J Kanki
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

7.  Distinct human immunodeficiency virus type 1 subtype A virus circulating in West Africa: sub-subtype A3.

Authors:  Seema Thakore Meloni; Bohye Kim; Jean-Louis Sankalé; Donald J Hamel; Sodsai Tovanabutra; Souleymane Mboup; Francine E McCutchan; Phyllis J Kanki
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

8.  Development, evaluation, and validation of an oligonucleotide probe hybridization assay to subtype human immunodeficiency virus type 1 circulating recombinant form CRF02_AG.

Authors:  Harr F Njai; Gert Van der Auwera; Chiambah A Ngong; Leo Heyndrickx; Souleymane Sawadago; Hilton Whittle; Phillipe Nyambi; Robert Colebunders; Guido van der Groen; Wouter Janssens
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

9.  Recombination confounds the early evolutionary history of human immunodeficiency virus type 1: subtype G is a circulating recombinant form.

Authors:  Ana B Abecasis; Philippe Lemey; Nicole Vidal; Túlio de Oliveira; Martine Peeters; Ricardo Camacho; Beth Shapiro; Andrew Rambaut; Anne-Mieke Vandamme
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

Review 10.  Evolution and diversity of HIV-1 in Africa--a review.

Authors:  Maria A Papathanasopoulos; Gillian M Hunt; Caroline T Tiemessen
Journal:  Virus Genes       Date:  2003       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.